● Recruiting

Long-term Follow-up Study of BHC001 for TDT

Condition: Thalassemia, Beta · Sponsor: Bioray Laboratories

PhaseN/A

Planned participants6

Who can joinAll sexes, 5 Years to 35 Years

Healthy volunteersNo

About this study

Observe long-term safety risk and long-term efficacy after intravenous infusion of BHC001 in TDT subjects.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaochen Wang, PhD · 021-64340008 · xcwang@brlmed.com

Always discuss trial participation with your own doctor first.

Locations (2)

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army	Nanning, Guangxi, China	Recruiting
Xiangya Hospital of Central South University	Changsha, Hunan, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06314529